Literature DB >> 24147255

Role of osteoclasts in regulating hematopoietic stem and progenitor cells.

Takeshi Miyamoto1.   

Abstract

Bone marrow (BM) cavities are utilized for hematopoiesis and to maintain hematopoietic stem cells (HSCs). HSCs have the ability to self-renew as well as to differentiate into multiple different hematopoietic lineage cells. HSCs produce their daughter cells throughout the lifespan of individuals and thus, maintaining HSCs is crucial for individual life. BM cavities provide a specialized microenvironment termed "niche" to support HSCs. Niches are composed of various types of cells such as osteoblasts, endothelial cells and reticular cells. Osteoclasts are unique cells which resorb bones and are required for BM cavity formation. Loss of osteoclast function or differentiation results in inhibition of BM cavity formation, an osteopetrotic phenotype. Osteoclasts are also reportedly required for hematopoietic stem and progenitor cell (HSPC) mobilization to the periphery from BM cavities. Thus, lack of osteoclasts likely results in inhibition of HSC maintenance and HSPC mobilization. However, we found that osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization by using three independent osteoclast-less animal models. In this review, I will discuss the roles of osteoclasts in hematopoietic stem cell maintenance and mobilization.

Entities:  

Keywords:  C-Fos; Hematopoietic stem and progenitor cell; Mobilization; Osteoclasts; Osteomac; Osteopetrosis; Osteoprotegerin; Receptor activator of nuclear factor kappa B ligand; op/op

Year:  2013        PMID: 24147255      PMCID: PMC3801239          DOI: 10.5312/wjo.v4.i4.198

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  111 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow.

Authors:  Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  Role of osteoclasts in the hematopoietic stem cell niche formation.

Authors:  Anna Mansour; Abdelilah Wakkach; Claudine Blin-Wakkach
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

4.  Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Authors:  E Tsuda; M Goto; S Mochizuki; K Yano; F Kobayashi; T Morinaga; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

Review 5.  Denosumab in patients with cancer-a surgical strike against the osteoclast.

Authors:  Janet E Brown; Robert E Coleman
Journal:  Nat Rev Clin Oncol       Date:  2012-01-10       Impact factor: 66.675

6.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

Review 7.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

Authors:  Fumio Arai; Atsushi Hirao; Masako Ohmura; Hidetaka Sato; Sahoko Matsuoka; Keiyo Takubo; Keisuke Ito; Gou Young Koh; Toshio Suda
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

9.  Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.

Authors:  A Mizuno; N Amizuka; K Irie; A Murakami; N Fujise; T Kanno; Y Sato; N Nakagawa; H Yasuda; S Mochizuki; T Gomibuchi; K Yano; N Shima; N Washida; E Tsuda; T Morinaga; K Higashio; H Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

10.  Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor.

Authors:  X Q Yan; R Briddell; C Hartley; G Stoney; B Samal; I McNiece
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

View more
  9 in total

1.  ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1.

Authors:  Nidhi Rohatgi; Wei Zou; Patrick L Collins; Jonathan R Brestoff; Timothy H Chen; Yousef Abu-Amer; Steven L Teitelbaum
Journal:  Blood Adv       Date:  2018-10-09

Review 2.  The roles of Orai and Stim in bone health and disease.

Authors:  Lisa J Robinson; Harry C Blair; John B Barnett; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2019-06-05       Impact factor: 6.817

Review 3.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

4.  ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice.

Authors:  Xiao Chai; Deguan Li; Xiaoli Cao; Yuchen Zhang; Juan Mu; Wenyi Lu; Xia Xiao; Chengcheng Li; Juanxia Meng; Jie Chen; Qing Li; Jishi Wang; Aimin Meng; Mingfeng Zhao
Journal:  Sci Rep       Date:  2015-05-13       Impact factor: 4.379

5.  Excessive proliferation and impaired function of primitive hematopoietic cells in bone marrow due to senescence post chemotherapy in a T cell acute lymphoblastic leukemia model.

Authors:  Chuanhe Jiang; Xiaoxia Hu; Libing Wang; Hui Cheng; Yan Lin; Yakun Pang; Weiping Yuan; Tao Cheng; Jianmin Wang
Journal:  J Transl Med       Date:  2015-07-17       Impact factor: 5.531

Review 6.  Role of apoptosis in pathogenesis and treatment of bone-related diseases.

Authors:  Samaneh Mollazadeh; Bibi Sedigheh Fazly Bazzaz; Mohammad Amin Kerachian
Journal:  J Orthop Surg Res       Date:  2015-01-28       Impact factor: 2.359

7.  Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress.

Authors:  Wenyi Lu; Weimin Wang; Shujuan Wang; Yonghuai Feng; Kaiyan Liu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

Review 8.  New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients.

Authors:  Maria K Angelopoulou; Pantelis Tsirkinidis; Georgios Boutsikas; Theodoros P Vassilakopoulos; Panayiotis Tsirigotis
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

Review 9.  Bone marrow niche dysregulation in myeloproliferative neoplasms.

Authors:  Natalia Curto-Garcia; Claire Harrison; Donal P McLornan
Journal:  Haematologica       Date:  2020-04-02       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.